SureTrader
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

This changeover in the movie industry could be

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
wimuskyfisherman Member Profile
 
Followed By 5
Posts 1,247
Boards Moderated 0
Alias Born 11/26/14
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/16/2018 6:32:05 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 11:13:52 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/14/2018 6:54:36 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/9/2018 8:08:58 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/24/2018 8:04:28 AM
Intellipharmaceutics Provides Operational Update GlobeNewswire Inc. - 1/24/2018 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/5/2017 8:05:20 AM
Intellipharmaceutics Announces Receipt of Nasdaq Notice GlobeNewswire Inc. - 12/5/2017 8:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/4/2017 5:21:01 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/30/2017 10:51:14 AM
Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical GlobeNewswire Inc. - 11/30/2017 10:45:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/20/2017 5:20:34 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 10/18/2017 3:20:22 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/16/2017 6:03:43 AM
Intellipharmaceutics Announces Closing of US$4 Million Financing GlobeNewswire Inc. - 10/13/2017 5:45:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/13/2017 6:04:15 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/12/2017 4:07:48 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/11/2017 8:07:45 AM
Intellipharmaceutics Announces US$4 Million Registered Direct Offering GlobeNewswire Inc. - 10/11/2017 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/10/2017 5:25:56 PM
Intellipharmaceutics Announces Third Quarter 2017 Results GlobeNewswire Inc. - 10/10/2017 5:20:59 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/25/2017 7:12:00 AM
Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista™ NDA GlobeNewswire Inc. - 9/25/2017 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/20/2017 5:18:47 PM
Intellipharmaceutics Announces Receipt of Nasdaq Notice GlobeNewswire Inc. - 9/20/2017 5:10:00 PM
wimuskyfisherman   Thursday, 11/09/17 03:34:36 PM
Re: tilator post# 31181
Post # of 32837 
This changeover in the movie industry could be very disruptive. What I see is someone creating a business that will lower the cut for the theatre owners and people making the films. I don't see how they will get away with "eating someone else's lunch" while those people passively sit back and watch. Should be interesting.

A big problem I see is at times when they can fill the theatres easily at full price- premiers, weekends, holidays, etc. They are not going to like giving half the seats away at lower prices.

The reason I have not signed up for this service is I was able to get a Marcus Rewards card for free. On Tuesday nights all movies are $5 plus with the rewards program I get free popcorn as well. So I might go 1-2 times per month. Never more than 2... And I will get free popcorn too! And if I don't go at all, I pay nothing!


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist